Alpha 2.0
Login Register
» Articles » PMID: 23812467

A Pharmacologic Approach to the Use of Glyburide in Pregnancy

Overview
Journal Obstet Gynecol
Specialty Gynecology & Obstetrics
Date 2013 Jul 2
PMID 23812467
Citations 16
Authors
Steve N Caritis
Mary F Hebert
Affiliations
Soon will be listed here.
Abstract

Despite widespread use of glyburide to treat pregnancy-related hyperglycemia, the dosing regimen is based in large part on pharmacokinetic and pharmacodynamic studies in men and nonpregnant women. Like many medications used by pregnant women, adequate pharmacokinetic and pharmacodynamic data in pregnancy have been sorely lacking. This lack of information can lead to both overdosing with excessive side effects and underdosing with an inadequate therapeutic response. Both of these problems may apply to glyburide use in pregnancy. This commentary provides a pharmacologic basis for altering the glyburide administration regimen. Taking glyburide 1 hour before a meal may improve efficacy in patients with pregnancy-related hyperglycemia.

Citing Articles

Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic.

Mendez Y, Alpuing Radilla L, Delgadillo Chabolla L, Castillo Cruz A, Luna J, Surani S World J Diabetes. 2023; 14(8):1178-1193.

PMID: 37664480 PMC: 10473953. DOI: 10.4239/wjd.v14.i8.1178.

Glibenclamide Increases Nitric Oxide Levels and Decreases Oxidative Stress in an In Vitro Model of Preeclampsia.

Nunes P, Bueno Pereira T, Bertozzi Matheus M, Grandini N, Siqueira J, Correa C Antioxidants (Basel). 2022; 11(8).

PMID: 36009339 PMC: 9404919. DOI: 10.3390/antiox11081620.

Changing patterns in medication prescription for gestational diabetes during a time of guideline change in the USA: a cross-sectional study.

Venkatesh K, Chiang C, Castillo W, Battarbee A, Donneyong M, Harper L BJOG. 2021; 129(3):473-483.

PMID: 34605130 PMC: 8752504. DOI: 10.1111/1471-0528.16960.

Gestational Diabetes: Overview with Emphasis on Medical Management.

Lende M, Rijhsinghani A Int J Environ Res Public Health. 2020; 17(24).

PMID: 33371325 PMC: 7767324. DOI: 10.3390/ijerph17249573.

The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.

Blair R, Rosenberg E, Palermo N Curr Diab Rep. 2019; 19(12):158.

PMID: 31811400 PMC: 7213051. DOI: 10.1007/s11892-019-1243-1.

References
1.
Rendell M . The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs. 2004; 64(12):1339-58. DOI: 10.2165/00003495-200464120-00006. View
2.
Langer O, Conway D, Berkus M, Xenakis E, Gonzales O . A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000; 343(16):1134-8. DOI: 10.1056/NEJM200010193431601. View
3.
Hebert M, Ma X, Naraharisetti S, Krudys K, Umans J, Hankins G . Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009; 85(6):607-14. PMC: 2684566. DOI: 10.1038/clpt.2009.5. View
4.
Go E, Kyriakidou-Himonas M, Berelowitz M . Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes. Diabetes Metab Res Rev. 2004; 20(3):225-31. DOI: 10.1002/dmrr.443. View
5.
Sartor G, Melander A, SCHERSTEN B . Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia. 1980; 18(1):17-22. DOI: 10.1007/BF01228296. View